Common Contracts

5 similar Warrant Exchange Agreement contracts by Rexahn Pharmaceuticals, Inc.

Warrant Exchange Agreement
Warrant Exchange Agreement • September 11th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

This Warrant Exchange Agreement (the “Agreement”) is made and entered into as of September 10, 2020, by and between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder of the Existing Warrants (as defined below) (the “Holder”).

AutoNDA by SimpleDocs
Warrant Exchange Agreement
Warrant Exchange Agreement • September 11th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

This Warrant Exchange Agreement (the “Agreement”) is made and entered into as of September 10, 2020, by and between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder of the Existing Warrants (as defined below) (the “Holder”).

Warrant Exchange Agreement
Warrant Exchange Agreement • September 11th, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

This Warrant Exchange Agreement (the “Agreement”) is made and entered into as of September 10, 2020, by and between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder of the Existing Warrants (as defined below) (the “Holder”).

Warrant Exchange Agreement
Warrant Exchange Agreement • September 2nd, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

This Warrant Exchange Agreement (the “Agreement”) is made and entered into as of September 1, 2020, by and between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder of the Existing Warrants (as defined below) (the “Holder”).

Warrant Exchange Agreement
Warrant Exchange Agreement • August 3rd, 2020 • Rexahn Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware

This Warrant Exchange Agreement (the “Agreement”) is made and entered into as of July 31, 2020, by and between Rexahn Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned holder of the Existing Warrants (as defined below) (the “Holder”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!